Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Julie Goodman

TitleInstructor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Dodge DG, Engel AM, Prueitt RL, Peterson MK, Goodman JE. US EPA's TSCA risk assessment approach: a case study of asbestos in automotive brakes. Inhal Toxicol. 2021 Aug-Dec; 33(9-14):295-307. PMID: 34788178.
      View in: PubMed
    2. Cox LA, Goodman JE, Engel AM. Chronic inflammation, Adverse Outcome Pathways, and risk assessment: A diagrammatic exposition. Regul Toxicol Pharmacol. 2020 Jul; 114:104663. PMID: 32330641.
      View in: PubMed
    3. Goodman JE, Mayfield DB, Becker RA, Hartigan SB, Erraguntla NK. Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program. Regul Toxicol Pharmacol. 2020 Jun; 113:104639. PMID: 32147291.
      View in: PubMed
    4. Lynch HN, Prueitt RL, Goodman JE. Critique of the ACGIH 2016 derivation of toluene diisocyanate Threshold Limit Values. Regul Toxicol Pharmacol. 2018 Aug; 97:189-196. PMID: 29964120.
      View in: PubMed
    5. Goodman JE, Kennedy EM, Seeley M. Do individuals with asthma experience airway hyper-responsiveness after exposure to nitrogen dioxide? Regul Toxicol Pharmacol. 2017 Oct; 89:279-287. PMID: 28751262.
      View in: PubMed
    6. Zu K, Pizzurro DM, Lewandowski TA, Goodman JE. Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts. Regul Toxicol Pharmacol. 2017 Oct; 89:83-94. PMID: 28720346.
      View in: PubMed
    7. Goodman JE, Peterson MK, Hixon ML, Pacheco Shubin S. Derivation of an oral Maximum Allowable Dose Level for Bisphenol A. Regul Toxicol Pharmacol. 2017 Jun; 86:312-318. PMID: 28377091.
      View in: PubMed
    8. Lynch HN, Loftus CT, Cohen JM, Kerper LE, Kennedy EM, Goodman JE. Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer. Regul Toxicol Pharmacol. 2016 Dec; 82:53-93. PMID: 27765718.
      View in: PubMed
    9. Goodman JE, Zu K, Tao G, Kerper LE. Comment on "Exposure-response modeling of non-cancer effects in humans exposed to Libby Amphibole Asbestos; update" by Benson et al. (2015). Regul Toxicol Pharmacol. 2016 10; 80:268-9. PMID: 27235558.
      View in: PubMed
    10. Cox LA, Goodman JE. Re: "Estimating Causal Associations of Fine Particles With Daily Deaths in Boston". Am J Epidemiol. 2016 Mar 15; 183(6):593. PMID: 26888752.
      View in: PubMed
    11. Lynch HN, Goodman JE, Tabony JA, Rhomberg LR. Systematic comparison of study quality criteria. Regul Toxicol Pharmacol. 2016 Apr; 76:187-98. PMID: 26743741.
      View in: PubMed
    12. Lamb JC, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Staveley J, Swaen G, Van Der Kraak G, Williams AL. Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014). Regul Toxicol Pharmacol. 2015 Dec; 73(3):754-7. PMID: 26550933.
      View in: PubMed
    13. Prueitt RL, Cohen JM, Goodman JE. Evaluation of atherosclerosis as a potential mode of action for cardiovascular effects of particulate matter. Regul Toxicol Pharmacol. 2015 Nov 15; 73(2 Suppl):S1-15. PMID: 26474868.
      View in: PubMed
    14. Goodman JE, Sax SN, Lange S, Rhomberg LR. Are the elements of the proposed ozone National Ambient Air Quality Standards informed by the best available science? Regul Toxicol Pharmacol. 2015 Jun; 72(1):134-40. PMID: 25857292.
      View in: PubMed
    15. Petito Boyce C, Goodman JE, Sax SN, Loftus CT. Providing perspective for interpreting cardiovascular mortality risks associated with ozone exposures. Regul Toxicol Pharmacol. 2015 Jun; 72(1):107-16. PMID: 25817736.
      View in: PubMed
    16. Goodman JE, Seeley M, Mattuck R, Thakali S. Do group responses mask the effects of air pollutants on potentially sensitive individuals in controlled human exposure studies? Regul Toxicol Pharmacol. 2015 Apr; 71(3):552-64. PMID: 25667955.
      View in: PubMed
    17. Lamb JC, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Staveley J, Swaen G, Van Der Kraak G, Williams AL. Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. Regul Toxicol Pharmacol. 2014 Jun; 69(1):22-40. PMID: 24530840.
      View in: PubMed
    18. Goodman JE, Boyce CP, Pizzurro DM, Rhomberg LR. Strengthening the foundation of next generation risk assessment. Regul Toxicol Pharmacol. 2014 Feb; 68(1):160-70. PMID: 24342233.
      View in: PubMed
    19. Goodman JE, Peterson MK, Bailey LA, Kerper LE, Dodge DG. Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer. Regul Toxicol Pharmacol. 2014 Feb; 68(1):8-15. PMID: 24189076.
      View in: PubMed
    20. Rhomberg LR, Goodman JE. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol. 2012 Oct; 64(1):130-3. PMID: 22750031.
      View in: PubMed
    21. Goodman JE, Dodge DG, Bailey LA. A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide. Regul Toxicol Pharmacol. 2010 Nov; 58(2):308-22. PMID: 20627117.
      View in: PubMed
    22. Goodman JE, Kerper LE, Boyce CP, Prueitt RL, Rhomberg LR. Weight-of-evidence analysis of human exposures to dioxins and dioxin-like compounds and associations with thyroid hormone levels during early development. Regul Toxicol Pharmacol. 2010 Oct; 58(1):79-99. PMID: 20416351.
      View in: PubMed
    23. Bailey LA, Goodman JE, Beck BD. Proposal for a revised Reference Concentration (RfC) for manganese based on recent epidemiological studies. Regul Toxicol Pharmacol. 2009 Dec; 55(3):330-9. PMID: 19686793.
      View in: PubMed
    24. Goodman JE. Neurodevelopmental effects of decabromodiphenyl ether (BDE-209) and implications for the reference dose. Regul Toxicol Pharmacol. 2009 Jun; 54(1):91-104. PMID: 19249332.
      View in: PubMed
    25. Goodman JE, Gaylor D, Beyer LA, Rhomberg LR, Beck BD. Effects of MTBE on the reported incidence of Leydig cell tumors in Sprague-Dawley rats: range of possible Poly-3 results. Regul Toxicol Pharmacol. 2008 Apr; 50(3):273-84. PMID: 18241965.
      View in: PubMed
    Goodman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)